| 2025-12-12 |
详情>>
内部人交易：
Iwicki Mark T等共交易2笔
|
| 2025-11-12 |
股东大会：
将于2025-12-09召开股东大会
会议内容 ▼▲
- 1.Back-End Transactions a. Proposal 1a: Subject to certain conditions and provided that a certain Dutch tax ruling is obtained on or prior to the Subsequent Closing Date, to enter into a statutory merger (juridische fusie) under Dutch law pursuant to which Merus, as disappearing company, will merge with and into Merus Merger B.V. (“New TopCo”), as surviving company, and to approve, within the meaning of Section 2:107a of the Dutch Civil Code and to the extent required by applicable law, such statutory merger and the subsequent cancellation of all class A shares in the capital of New TopCo with repayment and distribution by New TopCo of an amount per class A share so cancelled equal to the Offer Consideration, without interest and subject to any applicable withholding taxes (voting item) b. Proposal 1b: Subject to certain conditions and provided that a certain Dutch tax ruling is not obtained ultimately on the Subsequent Closing Date, to amend Merus’ articles of association to increase Merus’ authorized share capital in one or more tranches, and promptly following the delisting of the Common Shares from the Nasdaq Global Market (“Nasdaq”), to convert Merus into a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) and to amend Merus’ articles of association (voting item)
2.Effective upon the acceptance for payment by Purchaser for all Common Shares validly tendered and not properly withdrawn pursuant to the Offer prior to the Expiration Time, to provide full and final discharge to each member of Merus’ board of directors (the “Merus Board” or the “Board”) for their acts of management or supervision, as applicable, up to and including the date of the EGM to the fullest extent permitted under applicable law
3.Appointment of Greg Mueller as non-executive director of Merus a. Proposal 3a: Opportunity for shareholders of Merus (“Merus Shareholders”) to make recommendations at the EGM to Merus’ non-executive directors in respect of their nomination to appoint a non-executive director (voting item) b. Nomination by Merus’ group of non-executive directors of Greg Mueller for appointment as non-executive director of Merus (discussion item) c. Proposal 3b: Appointment of Greg Mueller as non-executive director of Merus (voting item)
4.Appointment of Anthony Pagano as non-executive director of Merus a. Proposal 4a: Opportunity for Merus Shareholders to make recommendations at the EGM to Merus’ non-executive directors in respect of their nomination to appoint a non-executive director (voting item) b. Nomination by Merus’ group of non-executive directors of Anthony Pagano for appointment as non-executive director of Merus (discussion item) c. Proposal 4b: Appointment of Anthony Pagano as non-executive director of Merus (voting item)
5.Appointment of Martine van Vugt, Ph.D., as non-executive director of Merus a. Proposal 5a: Opportunity for Merus Shareholders to make recommendations at the EGM to Merus’ non-executive directors in respect of their nomination to appoint a non-executive director (voting item) b. Nomination by Merus’ group of non-executive directors of Martine van Vugt, Ph.D., for appointment as non-executive director of Merus (discussion item) c. Proposal 5b: Appointment of Martine van Vugt, Ph.D., as non-executive director of Merus (voting item)
6.Non-binding advisory proposal to approve certain compensation arrangements
|
| 2025-11-12 |
详情>>
股本变动：
变动后总股本7584.72万股
|
| 2025-10-31 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-4.87美元,归母净利润-3.5亿美元,同比去年增长-89.92%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益-3.64美元,归母净利润-2.55亿美元,同比去年增长-201.42%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益-1.4美元,归母净利润-9647.4万美元,同比去年增长-179.99%
|
| 2025-04-24 |
股东大会：
将于2025-05-21召开股东大会
会议内容 ▼▲
- 1.Opening.
2.Discussion of the Company’s Dutch statutory annual report over the financial year 2024 (discussion item).
3.Adoption of the Company’s Dutch statutory annual accounts over the financial year 2024 (voting item).
4.Explanation of the dividend and reservation policy (discussion item).
5.Appointment of the KPMG Accountants N.V. as the Company’s external auditor for the financial year 2025 for purposes of Dutch law (voting item).
6.Release of each member of the Company’s board of directors from liability for the exercise of their duties during the financial year 2024 (voting item).
7.Re-appointment of Anand Mehra, M.D. as non-executive director: Opportunity to make recommendations for nomination by the Company’s group of non-executive directors (voting item);Nomination by the Company’s group of non-executive directors of Anand Mehra, M.D. for re-appointment as non-executive director (discussion item);Re-appointment of Anand Mehra, M.D. as non-executive director (voting item).
8.Re-appointment of Maxine Gowen, Ph.D. as non-executive director:Opportunity to make recommendations for nomination by the Company’s group of non-executive directors (voting item);Nomination by the Company’s group of non-executive directors of Maxine Gowen, Ph.D. for re-appointment as non-executive director (discussion item);Re-appointment of Maxine Gowen, Ph.D. as non-executive director (voting item).
9.Granting authorization to the Company’s board of directors to acquire shares (or depository receipts for such shares) in the Company’s capital (voting item).
10.Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers (voting item).
11.Closing.
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益-2.92美元,归母净利润-1.31亿美元,同比去年增长-96.35%
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益-3.35美元,归母净利润-2.15亿美元,同比去年增长-38.97%
|
| 2024-10-31 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.94美元,归母净利润-1.84亿美元,同比去年增长-94.55%
|
| 2024-08-01 |
详情>>
业绩披露：
2023年中报每股收益-1.52美元,归母净利润-7177.4万美元,同比去年增长-191.68%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-1.41美元,归母净利润-8449.8万美元,同比去年增长-17.73%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益-0.59美元,归母净利润-3445.6万美元,同比去年增长13.30%
|
| 2024-04-10 |
股东大会：
将于2024-05-07召开股东大会
会议内容 ▼▲
- 1.Adoption of the Company’s Dutch statutory annual accounts over the financial year 2023
2.Appointment of KPMG Accountants N.V. as the Company’s external auditor for the financial year 2024 for purposes of Dutch law
3.Release of each member of the Company’s board of directors from liability for the exercise of their duties during the financial year 2023
4.Re-appointment of Mark Iwicki as non-executive director
5.Re-appointment of Paolo Pucci as non-executive director
6.Appointment of Jason Haddock as non-executive director
7.Articles Amendment A – Approval of amendment of the Articles of Association to increase the authorized share capital to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares and authorization to implement such amendment
8.Articles Amendment B – Approval of the amendment to the Articles of Association to reflect the Large Company Regime and authorization to implement such amendment
9.Granting authorization to acquire shares (or depository receipts for such shares) in the Company’s capital
10.Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers
11.Approval of the amendment of the Company’s Non-Executive Director Compensation program (“NED Program”) to allow the board of directors to determine the number of common shares that may be awarded to a non-executive director for initial and annual awards under the NED Program to more closely align with the 50th percentile of the Company’s peer group
12.Approval of the amendment and restatement of the Company’s 2016 Incentive Award Plan (the “2016 Plan”) to extend the term of the 2016 Plan to December 31, 2031, which includes a corresponding extension to the annual “evergreen” feature from and including January 1, 2026 to January 1, 2029, along with other minor amendments updated for best practices
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益-3美元,归母净利润-1.55亿美元,同比去年增长-18.1%
|
| 2023-11-02 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.91美元,归母净利润-9478.6万美元,同比去年增长-92.57%
|
| 2023-04-28 |
股东大会：
将于2023-05-26召开股东大会
会议内容 ▼▲
- 1.Discussion of the Dutch statutory annual report over the financial year 2022
2.Adoption of the Dutch statutory annual accounts over the financial year 2022
3.Explanation of the dividend and reservation policy
4.Appointment of the external auditor for the financial year 2023 for purposes of Dutch law
5.Release of each member of our board of directors from liability for the exercise of their duties
6.Re-appointment of Sven (Bill) Ante Lundberg, M.D. as executive director
7.Re-appointment of Anand Mehra, M.D. as non-executive director
8.Re-appointment of Victor Sandor, M.D.C.M. as non-executive director
9.Extending authorization of our board of directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company’s capital
10.Extending authorization of our board of directors to limit or exclude pre-emption rights
11.Granting authorization to acquire shares (or depository receipts for such shares) in the Company’s capital
12.Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers
|
| 2022-11-03 |
复牌提示：
2022-11-03 09:34:09 停牌，复牌日期 2022-11-03 09:44:09
|
| 2022-04-29 |
股东大会：
将于2022-05-31召开股东大会
会议内容 ▼▲
- 1.Opening
2.Discussion of the Dutch statutory annual report over the financial year 2021 (discussion item)
3.Adoption of the Dutch statutory annual accounts over the financial year 2021 (voting item)
4.Explanation of the dividend and reservation policy (discussion item)
5.Appointment of the external auditor for the financial year 2022 for purposes of Dutch law (voting item)
6.Release of each member of our board of directors from liability for the exercise of their duties (voting item)
7.Re-appointment of Len Kanavy as non-executive director (voting item)
8.Granting authorization to acquire shares (or depository receipts for such shares) in the Company’s capital (voting item)
9.Approval of the amendment of the Non-Executive Director Compensation Program (“NED Program”) to (i) increase the value of option awards granted under the NED Program to more closely align with the 50th percentile of the Company’s U.S. peer group, and (ii) increase the amount by which the grant date fair value of option awards granted under the NED Program increases annually from 3% to up to 5%. The number of shares subject to such awards will continue to be determined in accordance with the NED Program (voting item)
10.Approval, on an Advisory (Non-Binding) Basis, of the Compensation of Our Named Executive Officers (voting item)
11.Approval, on an Advisory (Non-Binding) Basis, of the Frequency of Future Advisory Votes on the Compensation of Our Named Executive Officers (voting item)
12.Closing
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-05-28召开股东大会
会议内容 ▼▲
- 1.Adoption of the Dutch statutory annual accounts over the financial year 2020
2.Appointment of the external auditor for the financial year 2021 for purposes of Dutch law
3.Release of each member of our board of directors from liability for the exercise of their duties during the financial year 2020
4.Appointment of Maxine Gowen, Ph.D. as non-executive director
5.Granting authorization to acquire shares (or depository receipts for such shares) in the Company’s capital
6.Articles Amendment A—Approval of amendment of Articles of Association to increase authorized share capital and authorization to implement such amendment
7.Articles Amendment B—Approval of amendment of Articles of Association to include U.S. federal forum selection clause and authorization to implement such amendment
|
| 2020-06-02 |
股东大会：
将于2020-06-30召开股东大会
会议内容 ▼▲
- 1.Opening
2.Discussion of the Dutch statutory annual report over the financial year 2019 (discussion item)
3.Adoption of the Dutch statutory annual accounts over the financial year 2019 (voting item)
4.Explanation of the dividend and reservation policy (discussion item)
5.Appointment of the external auditor for the financial year 2020 for purposes of Dutch law (voting item)
6.Release of the Company’s directors from liability for the exercise of their duties during the financial year 2019 (voting item)
7.Re-appointment of Mark Iwicki as non-executive director (voting item)
8.Re-appointment of Gregory D. Perry as non-executive director (voting item)
9.Appointment of Paolo Pucci as non-executive director (voting item)
10.Approval of the amendment of the terms applicable to options granted under the Company’s 2010 employee option plan to remove the pre-defined windows during which such options may be exercised (voting item)
11.Granting authorization to acquire shares (or depository receipts for such shares) in the Company’s capital (voting item)
12.Approval of the amendment of the Company’s Non-Executive Director Compensation Program (“NED Program”) to remove the limit on the number of shares that may be awarded to a non-executive director for initial and annual awards under the NED Program. The number of shares subject to such awards will continue to be determined by the grant date fair value set forth in the NED Program (voting item)
13.Closing
|
| 2019-12-16 |
股东大会：
将于2019-12-31召开股东大会
会议内容 ▼▲
- 1.Opening
2.Appointment of Dr. S.A. Lundberg as executive director (voting item)
3.Closing
|
| 2019-11-18 |
股东大会：
将于2019-12-05召开股东大会
会议内容 ▼▲
- 1.Opening
2.Amendment of the Company’s articles of association and authorization to implement such amendment (voting item)
3.Closing
|
| 2019-05-23 |
股东大会：
将于2019-06-12召开股东大会
会议内容 ▼▲
- 1.Opening
2.Discussion of the annual report over the financial year 2018 (discussion item)
3.Implementation of the compensation policy during the financial year 2018 (discussion item)
4.Adoption of the annual accounts over the financial year 2018 (voting item)
5.Explanation of the dividend and reservation policy (discussion item)
6.Appointment of the external auditor for the financial year 2019 (voting item)
7.Release of the Company’s directors from liability for the exercise of their duties during the financial year 2018 (voting item)
8.Amendment of the Company’s articles of association and authorization to implement such amendment (voting item)
9.Appointment of Dr. Victor Sandor as non-executive director (voting item)
10.Appointment of Dr. Sven Ante Lundberg as non-executive director (voting item)
11.Re-appointment of Dr. Anand Mehra as non-executive director (voting item)
12.Re-appointment of Dr. John de Koning as non-executive director (voting item)
13.Approval of amendment to awards granted under the Company’s 2010 employee option plan (voting item)
14.Granting authorization to acquire shares in the Company’s capital (voting item)
15.Closing
|
| 2018-07-05 |
股东大会：
将于2018-07-20召开股东大会
会议内容 ▼▲
- 1.Opening
2.Discussion of the annual report over the financial year 2017 (discussion item)
3.Discussion of the Company’s corporate governance (discussion item)
4.Implementation of the compensation policy during the financial year 2017 (discussion item)
5.Adoption of the annual accounts over the financial year 2017 (voting item)
6.Explanation of the dividend and reservation policy (discussion item)
7.Appointment of the external auditor for the financial year 2018 (voting item)
8.Release of the Company’s directors from liability for the exercise of their duties during the financial year 2017 (voting item)
9.Appointment of Mr Russell Greig as non-executive director (voting item)
10.Appointment of Mr Len Kanavy as non-executive director (voting item)
11.Approval of amendment to awards granted under the Company’s 2010 employee option plan (voting item)
12.Approval of amendment to the Non-Executive Director Compensation Program (voting item)
13.Granting authorization to issue shares and to grant rights to subscribe for shares (voting item)
14.Granting authorization to limit or exclude pre-emption rights (voting item)
15.Granting authorization to acquire shares in the Company’s capital (voting item)
16.Granting authorization to revise the call option agreement with the Company’s protective foundation (voting item)
17.Closing
|